Growth Metrics

Adient (ADNT) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Adient (ADNT) over the last 11 years, with Q4 2025 value amounting to $3.4 billion.

  • Adient's Cost of Revenue rose 451.36% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.7 billion, marking a year-over-year increase of 71.19%. This contributed to the annual value of $13.6 billion for FY2025, which is 135.17% down from last year.
  • As of Q4 2025, Adient's Cost of Revenue stood at $3.4 billion, which was up 451.36% from $3.4 billion recorded in Q3 2025.
  • Adient's Cost of Revenue's 5-year high stood at $3.8 billion during Q2 2023, with a 5-year trough of $2.7 billion in Q3 2021.
  • In the last 5 years, Adient's Cost of Revenue had a median value of $3.4 billion in 2023 and averaged $3.4 billion.
  • The largest annual percentage gain for Adient's Cost of Revenue in the last 5 years was 7380.55% (2021), contrasted with its biggest fall of 1843.68% (2021).
  • Adient's Cost of Revenue (Quarter) stood at $3.3 billion in 2021, then grew by 4.87% to $3.5 billion in 2022, then dropped by 1.56% to $3.4 billion in 2023, then decreased by 3.95% to $3.3 billion in 2024, then rose by 4.51% to $3.4 billion in 2025.
  • Its Cost of Revenue was $3.4 billion in Q4 2025, compared to $3.4 billion in Q3 2025 and $3.5 billion in Q2 2025.